GW Pharmaceuticals Plc (GWPH)

155.74
7.03 4.32
NASDAQ : Health Technology
Prev Close 162.77
Open 162.82
Day Low/High 155.34 / 163.18
52 Wk Low/High 90.14 / 179.65
Volume 608.41K
Avg Volume 466.80K
Exchange NASDAQ
Shares Outstanding 30.45M
Market Cap 5.25B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
'Mad Money' Lightning Round: Buy AT&T, Verizon, Walgreens Boots Alliance

'Mad Money' Lightning Round: Buy AT&T, Verizon, Walgreens Boots Alliance

Cramer says you have to be willing to take some pain on Radius Health and GW Pharmaceuticals.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

It's government shutdown season and that's never good for the stock market, Cramer says. So he'll be watching Washington as well as earnings from Johnson & Johnson and Wells Fargo.

'Mad Money' Lightning Round: Buy, Buy, Buy Blackstone and KKR

'Mad Money' Lightning Round: Buy, Buy, Buy Blackstone and KKR

Cramer favors Costco over Wal-Mart and sees GW Pharmaceuticals as a long-term holding.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer will be watching a plethora of economic data and earnings from Vail Resorts, Paychex and General Electric, among others.

Biotech Stock Mailbag: Bristol, Exelixis, Lion Bio, GW Pharma

Biotech Stock Mailbag: Bristol, Exelixis, Lion Bio, GW Pharma

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Cramer: I'm Impressed by GW Pharma's Cannabis Data, Wait to Buy Kimberly-Clark

Cramer: I'm Impressed by GW Pharma's Cannabis Data, Wait to Buy Kimberly-Clark

GW Pharma's drug showed impressive results for treating schizophrenia, Cramer says. Investors looking to buy high-quality consumer companies like Kimberly-Clark should wait for the Fed's rate decision.

Jim Cramer: Rite Aid and GW Pharmaceuticals Are Ripe for a Rally

Jim Cramer: Rite Aid and GW Pharmaceuticals Are Ripe for a Rally

Rite Aid and GW Pharmaceuticals both have positive catalysts — and bullish analyst coverage — to help push their share prices higher, Cramer says.

'Mad Money' Lightning Round: Sell, Sell, Sell LinkedIn

'Mad Money' Lightning Round: Sell, Sell, Sell LinkedIn

Cramer says we're too late on NutriSystem while AmerisourceBergen is a terrific buy.

Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China

Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China

China's problems continue to knock a number of U.S. stocks upside the head, Cramer says.

Jim Cramer's Top Takeaways: Domino's, GW Pharmaceuticals, Bed Bath & Beyond

Jim Cramer's Top Takeaways: Domino's, GW Pharmaceuticals, Bed Bath & Beyond

Cramer is sticking with Domino's in the pizza wars and he likes Bed Bath the store but not the stock.

Jim Cramer's 'Mad Money' Recap: Supreme Court Almost Makes Market Forget Greece

Jim Cramer's 'Mad Money' Recap: Supreme Court Almost Makes Market Forget Greece

Health care stocks rose after the High Court's ruling but don't expect magic for everyone until there's a Greek deal.

Marijuana Stocks and the Risks of a '420 Friendly' Portfolio

Marijuana Stocks and the Risks of a '420 Friendly' Portfolio

Want to invest in marijuana stocks? You'd better do your homework first -- otherwise, you might get burned.

Jim Cramer Explains What Markets Will Do When the Fed Raises Rates

Jim Cramer Explains What Markets Will Do When the Fed Raises Rates

Answering a viewer's Twitter question, Jim Cramer says market will dip for several weeks after the Federal Reserve raises rates.

Cramer: Markets to Dip for a Few Weeks When the Fed Raises Rates

Cramer: Markets to Dip for a Few Weeks When the Fed Raises Rates

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

GW Appoints Senior Industry Executive To President, North America And Relocates CEO To The U.S.

GW Appoints Senior Industry Executive To President, North America And Relocates CEO To The U.S.

U.S. Operations to be Located in Southern California

GW Pharmaceuticals Plc Reports Second Quarter 2015 Financial Results And Operational Progress

GW Pharmaceuticals Plc Reports Second Quarter 2015 Financial Results And Operational Progress

Conference Call Today at 8:00 a.m. EDT, 1:00 p.m. BST

Here's What's Driving Biotech

And it's not the favorable macroeconomic climate.